Investigator
Vikram R. Paralkar
UNIVERSITY OF PENNSYLVANIA · funded by NHLBI, NIGMS
- Companies
- 1
- Grants
- 2
- Non-dilutive funding
- $593k
- First award
- Aug 21, 2020
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Sep 1, 2024.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- CORIELL INSTITUTE FOR MEDICAL RESEARCH82momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R21
A map of ribosomal RNA regulation in human hematopoiesis
$122kSep 1, 2024NHLBIUNIVERSITY OF PENNSYLVANIANIH RePORTER · 11169056 (opens the source filing in a new tab)
- R35
Regulation of rRNA transcription in mammalian tissues
$471kAug 21, 2020NIGMSUNIVERSITY OF PENNSYLVANIANIH RePORTER · 11091206 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources